Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

(Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to ... The post-Consolidation Common Shares will continue to ...

Soon after starting a new biotechnology company, David Li realized he needed to rethink his strategy. Li had been conducting the competitive research biotech entrepreneurs typically undertake before ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...

The biotech sector is revolutionizing healthcare with tailored treatments driven by affordable genetic profiling, enhancing efficacy while reducing side effects. This innovation fuels robust demand ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...

At a time when pharma interest in AI capabilities is surging, it is no surprise that a biotech focused on using “emerging AI tools” in drug discovery and development would have such strong backing.

Zhengye Biotechnology announces full exercise of ... The shares began trading on the Nasdaq Capital Market under the ticker symbol "ZYBT" on January 7, 2025. Funds from the IPO will be used ...

14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq ... 2025 under the ticker symbol “ZYBT.” Proceeds from the Offering will be used for acquiring vaccine production ...